MedTrace Logo

Cardiovascular-Kidney-Metabolic Syndrome Registry

NCT07718789 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2250

Last updated 2026-07-22

No results posted yet for this study

Summary

The goal of this observational registry study is to learn about cardiovascular-kidney-metabolic syndrome, also called CKMS, among adults receiving care at tertiary care hospitals in India. CKMS describes the close relationship between excess body weight, metabolic conditions such as high blood pressure and diabetes, kidney disease, and cardiovascular disease.

The main questions this study aims to answer are:

* What proportion of participants are in each stage of CKMS when they enter the study?
* How do participants' CKMS stage and related health factors change over 12 months?
* How does participants' quality of life change over time?
* What are the prescription practices for CKMS?

Participants will:

* Provide information about their general health, medical history, lifestyle, current medicines, family history, and quality of life.
* Have measurements taken, including height, weight, waist circumference, and blood pressure.
* Provide blood and urine samples for tests related to blood sugar, cholesterol, kidney function, inflammation, and heart health.
* Undergo an electrocardiogram, also called an ECG, and a coronary artery calcium scan according to the study schedule.
* Return for follow-up visits at 6 months and 12 months after joining the study. Participants will continue to receive their usual medical care as decided by their treating doctor. No experimental medicine or treatment will be provided as part of this study.

This multi-centre registry will include approximately 2250 adults from five tertiary care hospitals in India. The information collected will help researchers understand the burden, progression, risk factors, quality of life, and treatment patterns of CKMS in India.

Conditions

  • Cardiovascular Kidney Metabolic Syndrome

Sponsors & Collaborators

  • Sun Pharmaceutical Industries Limited

    collaborator INDUSTRY

  • Centre for Chronic Disease Control, India

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-24
Primary Completion
2027-12-31
Completion
2027-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07718789 on ClinicalTrials.gov